Chris Kelly
About Chris Kelly
Chris Kelly serves as the Director of New Product Development and Quality Engineering at Biosense Webster, where he has worked since 2018. He specializes in developing diagnostic and therapeutic catheters for arrhythmia treatment and has a background in quality engineering within the medical device industry.
Work at BioSense Webster
Chris Kelly has been serving as the Director of New Product Development, Quality Engineering at BioSense Webster since 2018. In this role, he focuses on the development of diagnostic and therapeutic catheters specifically designed for arrhythmia treatment. His leadership in product development and quality engineering contributes to the advancement of medical devices in the field of electrophysiology. The position is based in Irwindale, California, where he has worked for six years.
Education and Expertise
Chris Kelly possesses extensive expertise in quality engineering within the medical device industry. His specialization includes the development of diagnostic and therapeutic catheters, which are critical for the treatment of arrhythmias. This technical knowledge supports his role in ensuring that new products meet regulatory standards and quality requirements.
Background
Prior to his current position at BioSense Webster, Chris Kelly worked at Baxter as an Engineer from 2001 to 2004. This experience provided him with a solid foundation in engineering principles and practices within the medical field. His career trajectory reflects a consistent focus on quality and product development in medical devices.
Professional Experience
Chris Kelly has accumulated significant experience in the medical device industry, particularly in quality engineering. His career spans over two decades, with a notable tenure at BioSense Webster and previous experience at Baxter. This background equips him with a comprehensive understanding of product development processes and quality assurance protocols.